Pfizer Approaches Medivation About Possible Acquisition
The San Francisco-based biotech company recently rejected a $9.3-billion takeover offer from Sanofi SA.
The San Francisco Business Times:
Pfizer Eyes This San Francisco Biotech Involved In Tight Acquisition War
Cancer drug developer Medivation Inc. has been approached by Pfizer Inc. for a takeover bid, just a week after the San Francisco company's board rejected a $9.3 billion offer from French drug giant Sanofi SA for being too low, Reuters reports. (McDermid, 5/4)